☆ 4.5 Article

Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy

HEPATOLOGY COMMUNICATIONS (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management

Josep M. Argiles et al.

Summary: Cachexia is a devastating syndrome characterized by substantial weight loss mainly in skeletal muscle and adipose tissue, which affects 50-80% of cancer patients. It is associated with systemic inflammation, anorexia, and increased energy expenditure. Understanding the underlying mechanisms and developing therapeutic approaches are essential.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma

Bang-Bin Chen et al.

Summary: Sarcopenia and myosteatosis are independent prognostic factors in patients who received immunotherapy for advanced HCC.

EUROPEAN RADIOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

Bernhard Scheiner et al.

Summary: The CRAFITY score is associated with survival and radiological response in patients receiving PD-(L)1 immunotherapy for hepatocellular carcinoma.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions

Abhilash Perisetti et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major global health concern. Sarcopenia, characterized by muscle loss, is a common problem in HCC and can have prognostic value. Current research aims to understand the role of sarcopenia in cirrhosis, especially in the context of HCC, and its implications for treatment outcomes. Sarcopenia has been shown to predict HCC-related mortality and efforts are being made to improve muscle health in these patients. Overall, sarcopenia is an important factor to consider in the management and prognosis of HCC patients.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Add to Collection

Review Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

Maria Reig et al.

Summary: There have been significant advances in the treatment strategies for hepatocellular carcinoma since the last update in 2018. However, some interventions still lack sufficient data for clinical incorporation, and personalized clinical management requires consideration of multiple parameters.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Oncology

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment

Takahiro Yamasaki et al.

Summary: Sarcopenia is associated with poor clinical outcomes in HCC patients receiving sorafenib or lenvatinib. The MS score, based on the positivity of three prognostic factors including skeletal MM, can be a reliable indicator of prolonged survival in patients receiving sorafenib.

LIVER CANCER (2022)

Add to Collection

Article Oncology

Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells

Man Zhao et al.

Summary: Sarcopenia and high systemic inflammation response index (SIRI) are independently associated with reduced survival in patients with hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs). The muscle mass and systemic inflammation levels of patients are closely related to overall survival and progression-free survival, highlighting the importance of considering these factors in treatment.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Nutrition & Dietetics

Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis

Chuan Jiang et al.

Summary: The prevalence of sarcopenia among patients with HCC was approximately 39%. Sarcopenia was independently associated with reduced overall survival (OS) and progression free survival (PFS) in HCC.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Oncology

Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma

Hiroaki Matsumoto et al.

Summary: The decrease of skeletal muscle mass index during atezolizumab plus bevacizumab therapy is significantly associated with poor progression-free survival in patients with unresectable hepatocellular carcinoma, while pretreatment sarcopenia is not a significant factor. Monitoring skeletal muscle volume during immunotherapy may be useful for predicting clinical outcomes.

CANCERS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor

Yusheng Guo et al.

Summary: This retrospective study assessed the relationship between sarcopenia and the prognosis of hepatocellular carcinoma patients treated with a PD-1 inhibitor. The results showed that patients with sarcopenia had a shorter progression-free survival, higher levels of inflammation, and lower levels of albumin.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

Matthias Pinter et al.

Summary: Studies on the application of ICBs in HCC patients are growing, but there are still challenges in patient selection. Combination therapy may show better efficacy in some cases, but caution is needed for specific patient populations.

GUT (2021)

Add to Collection

Review Oncology

The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review

Matthias Pinter et al.

Summary: Recent advancements in the treatment of advanced hepatocellular carcinoma (HCC) have led to the approval of new systemic therapies such as angiogenesis inhibitors and immune checkpoint blockers, indicating important progress in the field. Strategies to target immunosuppression in tumors, such as vascular endothelial growth factor pathway inhibition and transforming growth factor-beta pathway inhibition, show promise in enhancing the efficacy of immunotherapy in HCC. Successes and failures of these treatments have provided insights into implementing novel systemic therapy in HCC and improving immunotherapy efficacy for this disease.

JAMA ONCOLOGY (2021)

Add to Collection

Article Oncology

Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody

Mehmet Akce et al.

Summary: This study aimed to investigate the impact of sarcopenia, body mass index (BMI), and inflammatory biomarkers on survival in advanced hepatocellular carcinoma (HCC) patients treated with anti-PD-1 antibody-based immunotherapy. The results showed that higher baseline neutrophil-to-lymphocyte ratio (NLR) was associated with worse overall survival, while sex-specific sarcopenia and BMI <25 were also linked to poorer survival outcomes.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension

Rafael Paternostro et al.

Summary: This study found that sarcopenia has a major impact on clinical outcomes in patients with advanced chronic liver disease, both in compensated and decompensated patients. Sarcopenia independently doubled the risk of mortality regardless of the severity of portal hypertension.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Systemic treatment of hepatocellular carcinoma: An EASL position paper

Jordi Bruix et al.

Summary: Significant advances have been made in the systemic treatment of hepatocellular carcinoma in the last 5 years, with new drugs and treatment strategies emerging. Prolonged survival exceeding 2 years is expected in most patients, and selecting the right medication based on patient characteristics and preferences is crucial for sound therapeutic decisions.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Oncology

Sarcopenia in the Older Adult With Cancer

Grant R. Williams et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Review Geriatrics & Gerontology

Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis

Yukinori Takenaka et al.

Summary: Sarcopenia is negatively associated with the efficacy of immune checkpoint inhibitors, leading to poor survival and response in patients with sarcopenia across various tumor types. Melanoma and NSCLC outcomes were comparable with overall results. The presence of sarcopenia should be assessed pre-therapeutically for patient selection in clinical practice.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Add to Collection

Article Gastroenterology & Hepatology

mRECIST for HCC: Performance and novel refinements

Josep M. Llovet et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Oncology

C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

Tatsuya Yoshida et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Add to Collection

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Geriatrics & Gerontology

Sarcopenia: revised European consensus on definition and diagnosis

Alfonso J. Cruz-Jentoft et al.

AGE AND AGEING (2019)

Add to Collection

Article Gastroenterology & Hepatology

A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation

Elizabeth J. Carey et al.

HEPATOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation

Tobias Meischl et al.

PLOS ONE (2019)

Add to Collection

Article Gastroenterology & Hepatology

The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis

Rafael Paternostro et al.

LIVER INTERNATIONAL (2019)

Add to Collection

Article Immunology

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions

Rachel V. Jimenez et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Medicine, General & Internal

Skeletal muscle as potential central link between sarcopenia and immune senescence

Christopher Nelke et al.

EBIOMEDICINE (2019)

Add to Collection

Article Oncology

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A hypothesis-generator preliminary report

Alessio Cortellini et al.

THORACIC CANCER (2019)

Add to Collection

Article Gastroenterology & Hepatology

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort

Jeroen Laurens Ad van Vugt et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Riccardo Lencioni et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

Tim Meyer et al.

LIVER INTERNATIONAL (2017)

Add to Collection

Review Geriatrics & Gerontology

Inflammation and sarcopenia: A systematic review and meta-analysis

Giulia Bano et al.

MATURITAS (2017)

Add to Collection

Review Gastroenterology & Hepatology

Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions

M. Sinclair et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Add to Collection

Review Oncology

Cancer-related inflammation and treatment effectiveness

Connie I. Diakos et al.

LANCET ONCOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma

Wolfgang Sieghart et al.

HEPATOLOGY (2013)

Add to Collection

Review Oncology

Understanding the mechanisms and treatment options in cancer cachexia

Kenneth Fearon et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis

Aldo J. Montano-Loza et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Add to Collection

Article Medical Laboratory Technology

Interrater reliability: the kappa statistic

Mary L. McHugh

BIOCHEMIA MEDICA (2012)

Add to Collection

Review Oncology

Definition and classification of cancer cachexia: an international consensus

Kenneth Fearon et al.

LANCET ONCOLOGY (2011)

Add to Collection

Article Oncology

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

Carla M. M. Prado et al.

LANCET ONCOLOGY (2008)

Add to Collection

Review Multidisciplinary Sciences

Cancer-related inflammation

Alberto Mantovani et al.

NATURE (2008)

Add to Collection

Review Geriatrics & Gerontology

Sarcopenia: Causes, consequences, and preventions

TJ Marcell

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.